title: Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial.
abstract: The advent of anti-tumor necrosis factor (TNF) therapies revolutionized the treatment of inflammatory bowel disease. Adalimumab is a subcutaneous anti-TNF agent indicated for use in patients with moderate-to-severe Crohn's disease and those with moderate-to-severe ulcerative colitis. In both diseases, it can be used for both induction of remission and for maintenance of remission. This review focuses on its use in Crohn's disease as described in the EXTEND (Extend the Safety and Efficacy of Adalimumab through Endoscopic Healing) trial. Several clinical trials using traditional instruments to measure clinical response have had endoscopic substudies looking for endoscopic healing. The EXTEND trial is the first to use mucosal healing on endoscopy as a primary endpoint for patients with moderate-to-severe Crohn's disease and baseline ulcerative disease treated with continuous adalimumab. In this well designed trial, the primary endpoint was narrowly missed, but the secondary endpoints further the notion that mucosal healing should be a more mainstream measure of drug efficacy. How this will translate from clinical trials to the clinic is not yet clear, but identifying noninvasive markers for mucosal healing, and understanding the implications of mucosal healing for safety, resource utilization, and quality of life are all worthy targets for further study. The aim of this review is to understand the role of mucosal healing, safety profile, and efficacy in patients treated with anti-TNF therapy, with particular attention to adalimumab and the EXTEND trial.
authors.affiliation: VCUHS Center for Inflammatory Bowel Disease, Virginia Commonwealth University Health Center, Richmond, VA, USA.
authors.forename: Amon
authors.initials: A
authors.lastname: Asgharpour
authors.forename: Jianfeng
authors.initials: J
authors.lastname: Cheng
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Bickston
keywords: Crohn’s disease; adalimumab; clinical trials; inflammatory bowel disease; tumor necrosis factor
references.citation: World J Gastroenterol. 2013 Feb 21;19(7):968-78
references.pmid: 23467585
references.citation: Gastroenterology. 1976 Mar;70(3):439-44
references.pmid: 1248701
references.citation: Gastroenterol Hepatol (N Y). 2012 Jan;8(1):29-38
references.pmid: 22347830
references.citation: Ann Rheum Dis. 2009 Dec;68(12):1863-9
references.pmid: 19147611
references.citation: Am J Gastroenterol. 2004 Jul;99(7):1371-85
references.pmid: 15233681
references.citation: Gastroenterology. 2006 Feb;130(2):323-33; quiz 591
references.pmid: 16472588
references.citation: Ann Intern Med. 2007 Jun 19;146(12):829-38
references.pmid: 17470824
references.citation: N Engl J Med. 2004 Feb 26;350(9):876-85
references.pmid: 14985485
references.citation: Scand J Gastroenterol. 2013 May;48(5):543-51
references.pmid: 23477356
references.citation: N Engl J Med. 2010 Apr 15;362(15):1383-95
references.pmid: 20393175
references.citation: Gastroenterology. 1995 Jul;109(1):129-35
references.pmid: 7797011
references.citation: MAbs. 2010 Mar-Apr;2(2):137-47
references.pmid: 20190560
references.citation: Scand J Gastroenterol. 2012 Oct;47(10):1200-10
references.pmid: 22861799
references.citation: Gastroenterology. 1979 Oct;77(4 Pt 2):847-69
references.pmid: 38176
references.citation: Gastroenterology. 2007 Jan;132(1):52-65
references.pmid: 17241859
references.citation: World J Gastroenterol. 2012 Sep 21;18(35):4823-54
references.pmid: 23002356
references.citation: Arthritis Rheum. 2001 Dec;44(12):2862-9
references.pmid: 11762947
references.citation: Gastrointest Endosc. 2004 Oct;60(4):505-12
references.pmid: 15472670
references.citation: Am J Gastroenterol. 2010 Feb;105(2):289-97
references.pmid: 19861953
references.citation: Gastroenterology. 2002 Feb;122(2):512-30
references.pmid: 11832465
references.citation: Pharmacol Ther. 2008 Feb;117(2):244-79
references.pmid: 18155297
references.citation: Can J Gastroenterol. 2011 Sep;25(9):492-6
references.pmid: 21912760
references.citation: Gut. 1990 Mar;31(3):325-8
references.pmid: 2323598
references.citation: Adv Ther. 2012 Jul;29(7):620-34
references.pmid: 22843208
references.citation: Inflamm Bowel Dis. 2009 Sep;15(9):1295-301
references.pmid: 19340881
references.citation: Curr Opin Gastroenterol. 2011 Jul;27(4):346-57
references.pmid: 21654383
references.citation: Rev Gastroenterol Disord. 2004;4 Suppl 3:S10-7
references.pmid: 15580148
references.citation: Curr Drug Targets. 2012 Sep 1;13(10):1294-9
references.pmid: 22664087
references.citation: Am J Gastroenterol. 2008 Dec;103(12):3123-31
references.pmid: 18786111
references.citation: Ann Rheum Dis. 2013 Apr;72(4):517-24
references.pmid: 22562972
references.citation: Gut. 2007 Apr;56(4):453-5
references.pmid: 17369375
references.citation: Dan Med Bull. 1999 Nov;46(5):400-15
references.pmid: 10605619
references.citation: Gastrointest Endosc. 2006 Mar;63(3):433-42; quiz 464
references.pmid: 16500392
references.citation: Gastroenterology. 2010 Feb;138(2):463-8; quiz e10-1
references.pmid: 19818785
references.citation: Gastroenterology. 2007 Feb;132(2):763-86
references.pmid: 17258735
references.citation: Lancet. 2002 May 4;359(9317):1541-9
references.pmid: 12047962
references.citation: N Engl J Med. 2001 Oct 11;345(15):1098-104
references.pmid: 11596589
references.citation: Ann Surg. 1996 Oct;224(4):563-71; discussion 571-3
references.pmid: 8857860
references.citation: Gut. 1989 Jul;30(7):983-9
references.pmid: 2668130
references.citation: Curr Med Res Opin. 2008 Feb;24(2):319-28
references.pmid: 18067689
references.citation: Drugs. 2010;70(2):109-20
references.pmid: 20108987
references.citation: Gut. 2007 Sep;56(9):1232-9
references.pmid: 17299059
references.citation: Gastroenterology. 2012 May;142(5):1102-1111.e2
references.pmid: 22326435
references.citation: Gut. 1997 Apr;40(4):443-8
references.pmid: 9176068
references.citation: Gut. 2000 Sep;47(3):404-9
references.pmid: 10940279
references.citation: Arthritis Rheum. 2007 Sep;56(9):2886-95
references.pmid: 17729297
references.citation: Eur J Gastroenterol Hepatol. 2009 Nov;21(11):1302-9
references.pmid: 19465858
references.citation: Hepatogastroenterology. 2013 Sep;60(126):1333-42
references.pmid: 23340167
references.citation: N Engl J Med. 1987 Dec 24;317(26):1625-9
references.pmid: 3317057
references.citation: Gastroenterology. 1990 Oct;99(4):956-63
references.pmid: 2394349
references.citation: Am J Med. 2004 Mar 1;116(5):305-11
references.pmid: 14984815
references.citation: Gastroenterology. 2007 Jul;133(1):312-39
references.pmid: 17631151
references.citation: J Crohns Colitis. 2013 Dec;7(12):958-67
references.pmid: 23517933
references.citation: Nat Rev Gastroenterol Hepatol. 2011 Oct 04;8(11):646-56
references.pmid: 21970871
references.citation: Gut. 2002 May;50 Suppl 3:III37-42
references.pmid: 11953331
references.citation: Inflamm Bowel Dis. 2009 Oct;15(10):1599-604
references.pmid: 19653291
references.citation: Gut. 2004 Jan;53(1):70-7
references.pmid: 14684579